136 related articles for article (PubMed ID: 24332571)
1. Comparison of visual and automated assessment of tumour inflammatory infiltrates in patients with colorectal cancer.
Forrest R; Guthrie GJ; Orange C; Horgan PG; McMillan DC; Roxburgh CS
Eur J Cancer; 2014 Feb; 50(3):544-52. PubMed ID: 24332571
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
[TBL] [Abstract][Full Text] [Related]
3. The clinical utility of the local inflammatory response in colorectal cancer.
Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
[TBL] [Abstract][Full Text] [Related]
4. Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
Eur J Cancer; 2009 Aug; 45(12):2138-45. PubMed ID: 19409772
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer.
Richards CH; Roxburgh CS; Anderson JH; McKee RF; Foulis AK; Horgan PG; McMillan DC
Br J Surg; 2012 Feb; 99(2):287-94. PubMed ID: 22086662
[TBL] [Abstract][Full Text] [Related]
6. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue.
Nielsen HJ; Hansen U; Christensen IJ; Reimert CM; Brünner N; Moesgaard F
J Pathol; 1999 Dec; 189(4):487-95. PubMed ID: 10629548
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer.
Park JH; McMillan DC; Powell AG; Richards CH; Horgan PG; Edwards J; Roxburgh CS
Clin Cancer Res; 2015 Feb; 21(4):882-8. PubMed ID: 25473000
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of the role of inflammation in renal cancer.
Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
[TBL] [Abstract][Full Text] [Related]
9. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
[TBL] [Abstract][Full Text] [Related]
10. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas.
Acikalin MF; Oner U; Topçu I; Yaşar B; Kiper H; Colak E
Dig Liver Dis; 2005 Mar; 37(3):162-9. PubMed ID: 15888280
[TBL] [Abstract][Full Text] [Related]
11. The relationships between plasma and red cell vitamin B2 and B6 concentrations and the systemic and local inflammatory responses in patients with colorectal cancer.
Leung EY; Roxburgh CS; Talwar D; O'Reilly DS; McKee RF; Horgan PG; McMillan DC
Nutr Cancer; 2012; 64(4):515-20. PubMed ID: 22439733
[TBL] [Abstract][Full Text] [Related]
12. The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer.
Richards CH; Flegg KM; Roxburgh CS; Going JJ; Mohammed Z; Horgan PG; McMillan DC
Br J Cancer; 2012 Jun; 106(12):2010-5. PubMed ID: 22596238
[TBL] [Abstract][Full Text] [Related]
13. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
[TBL] [Abstract][Full Text] [Related]
14. The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma.
Jamieson NB; Mohamed M; Oien KA; Foulis AK; Dickson EJ; Imrie CW; Carter CR; McKay CJ; McMillan DC
Ann Surg Oncol; 2012 Oct; 19(11):3581-90. PubMed ID: 22555345
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and prognosis in colorectal cancer.
Klintrup K; Mäkinen JM; Kauppila S; Väre PO; Melkko J; Tuominen H; Tuppurainen K; Mäkelä J; Karttunen TJ; Mäkinen MJ
Eur J Cancer; 2005 Nov; 41(17):2645-54. PubMed ID: 16239109
[TBL] [Abstract][Full Text] [Related]
16. The local inflammatory response in colorectal cancer - Type, location or density? A systematic review and meta-analysis.
Alexander PG; McMillan DC; Park JH
Cancer Treat Rev; 2020 Feb; 83():101949. PubMed ID: 31869737
[TBL] [Abstract][Full Text] [Related]
17. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer.
Roxburgh CS; McMillan DC
Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823
[TBL] [Abstract][Full Text] [Related]
18. An improved procedure to quantify tumour vascularity using true colour image analysis. Comparison with the manual hot-spot procedure in a human melanoma xenograft model.
van der Laak JA; Westphal JR; Schalkwijk LJ; Pahlplatz MM; Ruiter DJ; de Waal RM; de Wilde PC
J Pathol; 1998 Feb; 184(2):136-43. PubMed ID: 9602703
[TBL] [Abstract][Full Text] [Related]
19. Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer?
Guthrie GJ; Roxburgh CS; Horgan PG; McMillan DC
Cancer Treat Rev; 2013 Feb; 39(1):89-96. PubMed ID: 22858249
[TBL] [Abstract][Full Text] [Related]
20. Aggressive colorectal carcinoma phenotypes of invasion can be assessed reproducibly and effectively predict poor survival: interobserver study and multivariate survival analysis of a prospectively collected series of 299 patients after potentially curative resections with long-term follow-up.
Wöhlke M; Schiffmann L; Prall F
Histopathology; 2011 Nov; 59(5):857-66. PubMed ID: 22092397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
